| FDA Puts Opioids, Compounding, Stem Cells at Forefront of Enforcement Efforts
For drug compounding, Wood pointed to issues with sterile drugs, while Donald Ashley, director of CDER's Office of Compliance, noted that one out of every four drug compounding inspections led to a recall in 2017. Ashley added that in 2017, FDA conducted 141 inspections of compounders, issued 62 ..
|
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Wednesday, December 6, 2017
High Importance!! FDA puts Compounding at Forefront as one of its Enforcement Efforts: one out of every four drug compounding inspections led to a recall in 2017
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment